{"disease":{"id":"early-stage","name":"early stage"},"drugs":{"marketed":[],"pipeline":[{"drug_id":"fordadistrogene-movaparvovec","indication_name":"Duchenne Muscular Dystrophy (early-stage)","indication_type":"pipeline","phase":"Phase 3","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"fordadistrogene movaparvovec","generic_name":"fordadistrogene-movaparvovec","company_name":"Pfizer Inc.","drug_phase":"discontinued","molecular_target":"Dystrophin gene (DMD); AAV9 receptor (AAVR)","drug_class":"Gene therapy; In vivo gene delivery","quality_score":null,"revenue":null,"mechanism":"Fordadistrogene movaparvovec delivers a functional dystrophin gene via AAV9 vector to restore muscle protein expression in Duchenne muscular dystrophy."}],"offLabel":[],"totalMarketed":0,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT07521397","title":"Pooled Analysis of Patients With Early-stage Breast Cancer Treated With Adjuvant Dose-dense Sequential Chemotherapy: a Hellenic Cooperative Oncology Group (HeCOG) Study.","phase":"","overall_status":"COMPLETED","enrollment_count":5358,"lead_sponsor_name":"Hellenic Cooperative Oncology Group","has_results":false},{"nct_id":"NCT04842617","title":"Phase III Study ：SHR6390/Placebo Combined With Endocrine Therapy for the Adjuvant Treatment of Hormone Receptor Positive,Human Epidermal Receptor 2 Negative","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":5274,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT07030231","title":"Use of Intraoperative Radiotherapy in Breast Cancer","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":3000,"lead_sponsor_name":"Parc de Salut Mar","has_results":false},{"nct_id":"NCT07153757","title":"De-escalation Therapy in Stage I ER-Positive Breast Cancer: A Non-Inferiority Trial","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":2934,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT07408830","title":"VA Randomized Trial of Surveillance Intervals After Transurethral Resection of High Grade Bladder Tumors","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":2482,"lead_sponsor_name":"VA Office of Research and Development","has_results":false},{"nct_id":"NCT02474641","title":"Hypofractionation With Simultaneous Integrated Boost vs. Standard Fractionation in Early Breast Cancer","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2324,"lead_sponsor_name":"University Hospital Schleswig-Holstein","has_results":false},{"nct_id":"NCT05957068","title":"Breast Cancer Exercise Intervention Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":2156,"lead_sponsor_name":"National Cancer Centre, Singapore","has_results":false},{"nct_id":"NCT05906407","title":"COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"German Cancer Research Center","has_results":false},{"nct_id":"NCT06876714","title":"ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":1524,"lead_sponsor_name":"Alliance for Clinical Trials in Oncology","has_results":false},{"nct_id":"NCT04003558","title":"Deep Learning Algorithms for Prediction of Lymph Node Metastasis and Prognosis in Breast Cancer MRI Radiomics (RBC-01)","phase":"","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT05812807","title":"Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":1295,"lead_sponsor_name":"Alliance for Clinical Trials in Oncology","has_results":false},{"nct_id":"NCT06637202","title":"Swebcg 91:A RT. Breast Conserving Surgery With or Without Radiotherapy for Breast Cancer Patients","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1187,"lead_sponsor_name":"Region Skane","has_results":false},{"nct_id":"NCT06728527","title":"PARTial BREast RECONstruction With Chest Wall Perforator Flap","phase":"","overall_status":"RECRUITING","enrollment_count":1001,"lead_sponsor_name":"Cambridge University Hospitals NHS Foundation Trust","has_results":false},{"nct_id":"NCT04603209","title":"Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Saint John's Cancer Institute","has_results":false},{"nct_id":"NCT07483996","title":"Cryoablation Versus Lumpectomy in Early-Stage Breast Cancer","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":938,"lead_sponsor_name":"Franciscus Gasthuis & Vlietland (Hospital)","has_results":false},{"nct_id":"NCT03077841","title":"Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer","phase":"PHASE2, PHASE3","overall_status":"SUSPENDED","enrollment_count":928,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT04607473","title":"ABUS for Early-stage Breast Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":675,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT07005999","title":"Interventional Ablation for Early-stage Lung Cancer","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":656,"lead_sponsor_name":"Guangzhou Institute of Respiratory Disease","has_results":false},{"nct_id":"NCT07098507","title":"De-escalation in Axillary Surgery for Early-stage Breast Cancer","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":620,"lead_sponsor_name":"Clinical Hospital Center Rijeka","has_results":false},{"nct_id":"NCT07214974","title":"Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device.","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Noah Tech, Corp.","has_results":false},{"nct_id":"NCT04287712","title":"Detection of Lung Cancer by Plasma Lipids","phase":"","overall_status":"COMPLETED","enrollment_count":558,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT03102307","title":"Registry Trial to Evaluate the Clinical Utilization of Targeted Axillary Dissection (TAD)","phase":"","overall_status":"COMPLETED","enrollment_count":548,"lead_sponsor_name":"Kliniken Essen-Mitte","has_results":false},{"nct_id":"NCT07484763","title":"Predicting Recurrence in HR+/HER2- Early Breast Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Shengjing Hospital","has_results":false},{"nct_id":"NCT04658186","title":"A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":496,"lead_sponsor_name":"UCB Biopharma SRL","has_results":true},{"nct_id":"NCT06938542","title":"Palliative Care Needs of Children With Rare Diseases and Their Families","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":480,"lead_sponsor_name":"Children's National Research Institute","has_results":false},{"nct_id":"NCT06733311","title":"A Study Developing a Non-invasive Urine-based Proteomic Model for Early Lung Cancer Detection.","phase":"","overall_status":"UNKNOWN","enrollment_count":480,"lead_sponsor_name":"Beijing Chao Yang Hospital","has_results":false},{"nct_id":"NCT06737107","title":"Multicenter Analysis of Different Approaches in Segmentectomies in Early-stage Lung Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":472,"lead_sponsor_name":"Scientific Institute San Raffaele","has_results":false},{"nct_id":"NCT05377684","title":"Study of Quality of Life and Hormone Levels in Premenopausal Participants With Early Breast Cancer Receiving Triptorelin Plus Additional Cancer Treatment","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":450,"lead_sponsor_name":"Ipsen","has_results":false},{"nct_id":"NCT05386719","title":"Cardiometabolic Screening Program","phase":"NA","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT02140021","title":"Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer","phase":"NA","overall_status":"TERMINATED","enrollment_count":409,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT06970912","title":"ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":393,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT05342350","title":"International Study of High-Risk Patients for Hepatocellular Carcinoma Using Liquid Biopsy","phase":"","overall_status":"TERMINATED","enrollment_count":360,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT07128199","title":"A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":360,"lead_sponsor_name":"Taiho Oncology, Inc.","has_results":false},{"nct_id":"NCT04109391","title":"Extension Study to Provide Adjuvant Treatment Following Neoadjuvant Treatment and Surgical Resection in Protocol TX05-03","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":338,"lead_sponsor_name":"Tanvex BioPharma USA, Inc.","has_results":true},{"nct_id":"NCT06995118","title":"The Application of \"HUAXI Hole 1\" in Reverse-sequence Endoscopic Nipple-sparing Mastectomy With Direct-to-implant Breast Reconstruction","phase":"NA","overall_status":"RECRUITING","enrollment_count":337,"lead_sponsor_name":"Du Zhenggui","has_results":false},{"nct_id":"NCT05048173","title":"Sentinel Lymph Node Biopsy Versus Lymphadenectomy in Endometrial Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":334,"lead_sponsor_name":"Far Eastern Memorial Hospital","has_results":false},{"nct_id":"NCT03797248","title":"Prospective Cohort Study of Traditional Chinese Medicine for Survival of Patients With Early Breast Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":310,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT07331506","title":"Validation of the Oncoliq Test for the Early Detection of Breast Cancer.","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Oncoliq US Inc","has_results":false},{"nct_id":"NCT05760612","title":"Adjuvant Trastuzumab Plus Neratinib in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Neoadjuvant Trastuzumab Plus Pertuzumab","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT06035016","title":"Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2 Positive Early-stage Breast Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT07196592","title":"Development of a Novel Multidimensional Therapeutic Intervention Protocol for MCI","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Yuan Shen","has_results":false},{"nct_id":"NCT05345860","title":"Adopting the MRD Strategy to Optimize Post-operation Adjuvant Therapies for Early Stage Breast Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT06834204","title":"Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":266,"lead_sponsor_name":"Rutgers, The State University of New Jersey","has_results":false},{"nct_id":"NCT07484087","title":"Ablation Compare With Surgery for Early Breast Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":264,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT03948568","title":"Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":262,"lead_sponsor_name":"Ottawa Hospital Research Institute","has_results":false},{"nct_id":"NCT07167459","title":"Personalized SBRT in Early-Stage Peripheral NSCLC","phase":"PHASE2","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":251,"lead_sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","has_results":false},{"nct_id":"NCT07317778","title":"Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":249,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT04829643","title":"Axillary Staging in Early Breast Cancer: SNB vs PET/MRI","phase":"NA","overall_status":"COMPLETED","enrollment_count":246,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT04781959","title":"A Randomized, Multicenter Pragmatic Trial Comparing Bone Pain From a Single Dose of Pegfilgrastim to 5 Doses of Daily Filgrastim in Breast Cancer Patients Receiving Neoadjuvant/Adjuvant Chemotherapy","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":233,"lead_sponsor_name":"Ottawa Hospital Research Institute","has_results":false},{"nct_id":"NCT03664687","title":"Comparing a Single-Dose vs. Twice Yearly Zoledronate in Patients With Early Stage Breast Cancer (REaCT-ZOL)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":211,"lead_sponsor_name":"Ottawa Hospital Research Institute","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}